As of 2026-10-10, the Intrinsic Value of Oncolytics Biotech Inc (ONC.TO) is -1.27 CAD. This ONC.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.42 CAD, the upside of Oncolytics Biotech Inc is -189.72%.
Based on its market price of 1.42 CAD and our intrinsic valuation, Oncolytics Biotech Inc (ONC.TO) is overvalued by 189.72%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.27 - -1.27 | -1.27 | -189.72% |
| P/E | (0.02) - (0.05) | (0.03) | -101.8% |
| DDM - Stable | (2.37) - (7.75) | (5.06) | -456.5% |
| DDM - Multi | (0.04) - (0.10) | (0.06) | -104.0% |
| Market Cap (mil) | 169.48 |
| Beta | 0.89 |
| Outstanding shares (mil) | 119.35 |
| Enterprise Value (mil) | 166.31 |
| Market risk premium | 5.10% |
| Cost of Equity | 9.24% |
| Cost of Debt | 5.00% |
| WACC | 9.21% |